Papers/PMID:15136320
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13.
Archives of ophthalmology (Chicago, Ill. : 1960)2004The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
Zn(2+) — decreases all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“Participants randomly assigned to receive zinc had lower mortality than those not taking zinc (RR, 0.73; 95% CI, 0.61-0.89).”
Quoted verbatim from Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13.. - Study
- RCT
- Population
- AREDS participants (age-related eye disease), factorial randomisation to antioxidants, zinc, antioxidants plus zinc, or placebo; zinc-assigned arms (zinc alone and with antioxidants) compared with all not assigned zinc
Effect 0.73 risk ratio, 95% CI 0.61 to 0.89
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13.2004PMID:15136320Permalink